Vertessen, Karen
Luman, Marjolein
Swanson, James M.
Bottelier, Marco
Stoffelsen, Reino
Bet, Pierre
Wisse, Annemiek
Twisk, Jos W. R.
Oosterlaan, Jaap
Funding for this research was provided by:
Innovatiefonds Zorgverzekeraars (p3119, p3119, p3119)
Article History
Received: 6 July 2022
Accepted: 17 February 2023
First Online: 2 March 2023
Declarations
:
: The authors declare no competing interests.
: Karen Vertessen has been involved in a clinical trial sponsored by Takeda. The other authors have no conflicts of interest relevant to this article to disclose.
: The local ethics committee approved the study (METC VUMC, # 2016.594).
: Parents and children older than 11 years provided signed informed consent approved by the local ethics committee.
: All authors reviewed and revised the manuscript and approved the final manuscript as submitted and agree to be accountable for all aspects of the work.